DevOps explained — Venture Capital perspective

Kris Przybylak | Investor @
Inside Inovo
Published in
10 min readAug 27, 2020

DevOps are getting more and more popular for a reason. They enable a quick, secure and reliable way of developing, testing and shipping new features to the customers, so no wonder that many companies can’t imagine life without them. That’s why we have decided to investigate the topic and prepare a lightweight summary that will help non-technical audiences understand the concept and tools used in the process as well as highlight potential investment opportunities for us — the Venture Capital investors.

DevOps revolution

The DevOps movement gained momentum in 2018, but it had its beginnings around 2009 when John Allspaw and Paul Hammond from Flickr presented how Dev and Ops can cooperate to deliver 10+ deploys per day (deployed code is the code shipped to the customers). According to a survey from 2017 DevOps is becoming the norm. Roughly 2 years ago almost 50% of companies had DevOps implemented to some extent and the next 30% was planning to follow suit.

The best and biggest companies such as Netflix, Amazon, Facebook, CD Projekt, Ikea or Lego, have DevOps engineers in their ranks, but you can also spot dozens of them at startups like Revolut, Docplanner, Booksy, or Brainly.

But what exactly is DevOps?

Developers (Devs) build & ship features as quickly as possible while the IT Operations (Ops) deploy code from Devs and make sure systems never go down and fix them if they do so. Before DevOps, there was a conflict of interest because Ops were protecting the stability of systems, and they didn’t welcome changes made by Developers with open arms as they were constantly bringing instability.

After DevOps was introduced the conflict still exists, but now the relationship between these two parties is much more productive. But going back to the main question: the ultimate goal of DevOps is to build digital pipelines taking code from the Developer and shipping it…

Kris Przybylak | Investor @
Inside Inovo

I'm looking for Healthcare startups at seed stage. Preferably originating from CEE, and preferably targeting the US market